$Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia$

Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia

書目詳細資料
Main Authors:	Amarnani, R, Travis, S, Javaid, MK
格式:	Journal article
語言:	English
出版:	Oxford University Press 2020

相似書籍

Treating ‘osteoporosis’: a near miss in an unusual case of FGF-23-mediated hypophosphataemic osteomalacia
由: Mike Lin, et al.
出版: (2022-11-01)

A Rare Case of Hypophosphataemic Osteomalacia in von Recklinghausen Neurofibromatosis
由: Yasmine Makhlouf, et al.
出版: (2021-05-01)

Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment
由: L Aliberti, et al.
出版: (2023-01-01)

Burosumab - new potent treatment for X-linked hypophosphatemia and tumor-induced osteomalacia
由: Magda Wojtuś, et al.
出版: (2023-07-01)

Selective blood sampling for FGF-23 in tumor-induced osteomalacia
由: Hans-Christof Schober, et al.
出版: (2017-10-01)

Long-term iron polymaltose infusions associated with hypophosphataemic osteomalacia: a report of two cases and review of the literature
由: Ramy H. Bishay, et al.
出版: (2017-01-01)

Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
由: S. S. Rodionova, et al.
出版: (2019-12-01)

A Normal FGF23 Does Not Preclude Tumor‐Induced Osteomalacia
由: Neeharika Nandam, et al.
出版: (2021-02-01)

Diagnostic Modalities for FGF23-Producing Tumors in Patients with Tumor-Induced Osteomalacia
由: Seiji Fukumoto
出版: (2014-06-01)

An image of a FGF-23-producing tumor resulting in osteomalacia
由: Marcelo Giacomini Louça, et al.
出版: (2024-06-01)

Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption
由: Naoko Hidaka, et al.
出版: (2021-12-01)

Phosphopenic form of osteomalacia in a patient with FGF23 producing tumor
由: A. S. Pushkareva, et al.
出版: (2022-05-01)

Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia
由: Iris R. Hartley, et al.
出版: (2022-08-01)

Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
由: Hannan, F, et al.
出版: (2008)

De Novo Large Deletions in the <i>PHEX</i> Gene Caused X-Linked Hypophosphataemic Rickets in Two Italian Female Infants Successfully Treated with Burosumab
由: Carmine Pecoraro, et al.
出版: (2023-07-01)

Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO)
由: Yuka Kinoshita, et al.
出版: (2019-06-01)

A Case of Acute Prosthesis Migration after Femoral Head Replacement due to Osteomalacia by FGF23-Induced Tumor
由: Shinya Hayashi, et al.
出版: (2012-01-01)

Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin
由: Anke H. Hautmann, et al.
出版: (2014-01-01)

Lessons learnt from delayed diagnosis of FGF-23-producing tumour-induced osteomalacia and post-operative hungry bone syndrome
由: S. Kumar, et al.
出版: (2020-06-01)

Effects of burosumab on osteocalcin and bone mineral density in patient with 15-year history of nonremission tumor-induced osteomalacia initially treated with conventional therapy: Case report
由: Daichi Miyaoka, et al.
出版: (2020-12-01)

FGF-23 transmitted tumor – induced hypophosphatemic osteomalacia: A rare case of a young woman with recurrent fractures and review of the literature
由: Florian A. Frank, et al.
出版: (2022-04-01)

A case report to assess the safety and efficacy of Burosumab, an investigational antibody to FGF23, in a single pediatric patient with Epidermal Nevus Syndrome and associated hypophosphatemic rickets
由: Carson Huynh, et al.
出版: (2022-12-01)

Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report
由: Yuichi Takashi, et al.
出版: (2022-12-01)

Predicting the impact of PHEX, FGF23 and DMP1 gene variants found in Malaysian Malay patients with Hypophosphataemic Rickets through in silico analysis of protein function and mRNA secondary structure
由: Razali, Nurul Nadirah, et al.
出版: (2019)

Windswept lower limb deformities in patients with hypophosphataemic rickets
由: Ali Al Kaissi, et al.
出版: (2013-12-01)

A case report of mesenchymal scapular FGF secreting tumor: Importance of follow up in tumor induced osteomalacia
由: Trilok Shrivastava, MD, et al.
出版: (2021-04-01)

Tumor-induced osteomalacia
由: Zinan Yin, et al.
出版: (2018-12-01)

Tumor-induced osteomalacia
由: Pablo Florenzano, et al.
出版: (2017-12-01)

The role of narrowband ultraviolet B phototherapy in the treatment of refractory osteomalacia
由: João Teixeira, et al.
出版: (2024-10-01)

Long-term safety in adults with X-linked Hypophosphatemia (XLH) treated with Burosumab, a fully human monoclonal antibody against FGF23: Final results of a phase 3 trial
由: Peter Kamenický, et al.
出版: (2020-10-01)

Phosphorus-independent role of FGF23 in erythropoiesis and iron homeostasis.
由: Min Young Park, et al.
出版: (2024-01-01)

Seven novel mutations in the PEX gene indicate molecular heterogeneity for X-linked hypophosphataemic rickets.
由: Dixon, P, et al.
出版: (1996)

Burosumab for the treatment of cutaneous-skeletal hypophosphatemia syndrome
由: Lillian Abebe, et al.
出版: (2024-03-01)

Mapping of human X-linked hypophosphataemic rickets by multilocus linkage analysis.
由: Read, A, et al.
出版: (1986)

X-linked hypophosphataemic rickets due to pseudo-exons of the PHEX gene.
由: Christie, P, et al.
出版: (2000)

Bridging markers defining the map position of X linked hypophosphataemic rickets.
由: Thakker, R, et al.
出版: (1987)

Genetic basis of hereditary hypophosphataemic rickets and phenotype presentation in children and adults
由: Tavana, Nahid, et al.
出版: (2021)

Osteomalacia
由: Ricardo Cediel
出版: (1958-09-01)

Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia.
由: Ai-Luen Wu, et al.
出版: (2013-01-01)

Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking
由: Kanhasut, Karnpob, et al.
出版: (2023)